Abstract
Study design
Retrospective case series.
Objective
To report the clinical features and outcomes of spinal cord injury (SCI) patients with COVID-19 and to see if they are any different from COVID-19 in the general population.
Setting
A tertiary care hospital in North-East India.
Methods
Data of already diagnosed traumatic SCI patients with COVID-19 infection reporting to the COVID-19 management team (from June 2021 to November 2021) were collected. The source of data was hospital records (admitted patients) and home visits and teleconsultation logs (home isolation patients).
Results
There were eight traumatic SCI patients (five admitted, three in home isolation) with COVID-19 infection. Four patients had complete injury with American Spinal Injury Association Impairment Scale (AIS) Grade A, two with AIS Grade C, and one each of Grade B and D respectively. Five patients were cervical level injuries, and others were T10 level and below. Six patients were categorized as mild clinical illness and one each as moderate and severe illness. Cough was the most common symptom which was seen in seven patients. Only two patients needed oxygen therapy. All eight traumatic SCI patients recovered eventually from COVID-19 symptoms and regained their pre-COVID-19 functional status, 1 month after being free from COVID-19 symptoms.
Conclusion
The COVID-19 infection did not result in a worsening of functional ability among SCI people after 1-month post-recovery. It also did not affect the SCI patients in doing activities such as rehabilitation exercises at 6 months follow up.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 1 print issues and online access
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data generated during the study can be found within the article.
References
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382:1199–207.
WHO Director-General’s opening remarks at the media briefing on COVID-19. 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
Stawicki SP, Jeanmonod R, Miller AC, Paladino L, Gaieski DF, Yaffee AQ, et al. The 2019–2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: a joint American college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID19 working group consensus paper. J Glob Infect Dis. 2020;12:47.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.
Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021;49:15–28. https://doi.org/10.1007/s15010-020-01509-1.
Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023;64:90–107. https://doi.org/10.1007/s12016-022-08921-5
Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JIR, Franssen GHL, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 2021;11:e044640. https://doi.org/10.1136/bmjopen-2020-044640.
Cragg JJ, Noonan VK, Krassioukov A, Borisoff J. Cardiovascular disease and spinal cord injury: results from a national population health survey. Neurology. 2013;81:723–8.
Gater DR, Farkas GJ, Berg AS, Castillo C. Prevalence of metabolic syndrome in veterans with spinal cord injury. J Spinal Cord Med. 2019;42:86–93.
Cragg JJ, Noonan VK, Dvorak M, Krassioukov A, Mancini GB, Borisoff JF. Spinal cord injury and type 2 diabetes: results from a population health survey. Neurology. 2013;81:1864–8.
Korupolu R, Stampas A, Gibbons C, Jimenez IH, Skelton F, Verduzco-Gutierrez M. COVID-19: screening and triage challenges in people with disability due to spinal cord injury. Spinal Cord Ser Cases. 2020;6:35.
López-Dolado E, Gil-Agudo A. Lessons learned from the coronavirus disease 2019 (Covid-19) outbreak in a monographic center for spinal cord injury. Spinal Cord. 2020;58:517–9.
Riegger T, Conrad S, Liu K, Schluesener HJ, Adibzahdeh M, Schwab JM. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur J Neurosci. 2007;25:1743–7.
Dicks MA, Clements ND, Gibbons CR, Verduzco-Gutierrez M, Trbovich M. Atypical presentation of Covid-19 in persons with spinal cord injury. Spinal Cord Ser Cases. 2020;6:38.
Marino RJ, Barros T, Biering-Sorensen F. International standards for neurological classification of spinal cord injury. J Spinal Cord Med. 2003;26:S50–S56.
Government of India Ministry of Health and Family Welfare. Clinical management protocol for covid-19 (in adults) version 6. Available from URL: https://www.mohfw.gov.in/pdf/updateddetailedclinicalmanagementprotocolforcovid19adultsdated24052021.pdf.
RodrÃguez-Cola M, Jiménez-Velasco I, Gutiérrez-Henares F, López-Dolado E, Gambarrutta-Malfatti C, Vargas-BaqueroE, et al. Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury. Spinal Cord Ser Cases. 2020;6:39.
Burns SP, Eberhart AC, Sippel JL, Wilson GM, Evans CT. Case fatality with coronavirus disease 2019 (COVID-19) in United States veterans with spinal cord injuries and disorders. Spinal Cord. 2020;58:1040–1.
D’Andrea S, Berardicurti O, Berardicurti A, Felzani G, Francavilla F, Francavilla S, et al. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study. Spinal Cord Ser Cases. 2020;6:69.
Galea MD, Gelman MA, Galea VP, Raulkar KP, Kornfeld S, Johnson-Kunjukutty S, et al. COVID-19 in spinal cord injury patients at a veterans administration hospital: a case series. J Spinal Cord Med. 2021;1:13.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.
Macera M, De Angelis G, Sagnelli C, Coppola N. Clinical Presentation of COVID-19: case series and review of the literature. Int J Environ Res Public Health. 2020;17:5062. https://doi.org/10.3390/ijerph17145062.
Thevarajan I, Buising KL, Cowie BC. Clinical presentation and management of COVID-19. Med J Aust. 2020;213:134–9. https://doi.org/10.5694/mja2.50698.
Barman A, Roy SS, Sasidharan SK, Sahoo J. Clinical features and prognosis of COVID-19/SARS-CoV-2 infections in persons with spinal cord injury: a review of current literature. Spinal Cord Ser Cases. 2021;7:58.
Zu-Li Z, Yu-Lei H, De-Tao L, Feng-Zeng L. Laboratory findings of COVID-19: a systematic review and meta-analysis. Scand J Clin Lab Investig. 2020;80:441–7. https://doi.org/10.1080/00365513.2020.1768587.
Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 2020;510:475–82. https://doi.org/10.1016/j.cca.2020.08.019.
Xie Y, Wang Z, Liao H, Marley G, Wu D, Tang W. Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis. BMC Infect Dis. 2020;20:640. https://doi.org/10.1186/s12879-020-05371-2.
Bauman WA, La Fountaine MF, Spungen AM. Age-related prevalence of low testosterone in men with spinal cord injury. J Spinal Cord Med. 2014;37:32–39.
Barbonetti A, Vassallo MRC, Felzani G, Francavilla S, Francavilla F. Association between 25(OH)-vitamin D and testosterone levels: evidence from men with chronic spinal cord injury. J Spinal Cord Med. 2016;39:246–52.
Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: serendipity or opportunity for intervention? Cancer Discov. 2020;10:779–82.
Calvo E, Corbacho-Alonso N, Sastre-Oliva T, Nuñez E, Baena-Galan P, Hernandez-Fernandez G, et al. Why Does COVID-19 affect patients with spinal cord injury milder? a case-control study: results from two observational cohorts. J Pers Med. 2020;10:182.
Messner CB, Demichev V, Wendisch D, Michalick L, White M, Freiwald A, et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst. 2020;11:11–24.
Acknowledgements
The authors sincerely thank the participants and their families. The authors also thank the COVID-19 management team, Zoram Medical College, Falkawn, Mizoram, India for providing overall administrative, technical and material support.
Author information
Authors and Affiliations
Contributions
CZ and ARC conceived and designed the study, played an important role in interpreting the results, and drafted and revised the manuscript. VH, JCV, and LS designed the study, acquired data, and played an important role in interpreting the results along with drafting the manuscript. CZ was also additionally involved in acquiring data. ARC revised the different versions of the draft manuscript and finalized the final version which was approved by all the authors. All the authors agree to be accountable for all aspects of the work. ARC confirms that she had full access to the data in the study and takes final responsibility for submitting the article for publication.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
All procedures involving human participants were in accordance with the Declaration of Helsinki 1964 as revised in 2013 and its later amendments or comparable ethical standards. The Institutional Ethics Committee, Zoram Medical College, Falkawn, Mizoram, India approved the retrospective study (No. F.20016/1/18-ZMC/IEC/63).
Informed consent
The Institutional Ethics Committee waived the requirement for informed written consent due to the retrospective nature of the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zonunsanga, C., Hruaii, V., Vanlalsanga, J.C. et al. Clinical profile of COVID-19 infection among persons with spinal cord injury: a case series. Spinal Cord Ser Cases 9, 34 (2023). https://doi.org/10.1038/s41394-023-00592-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41394-023-00592-4